|
Volumn 25, Issue 5, 2005, Pages 400-403
|
Effect of astraglus injection on serum apoptosis relevant factors in patients with chronic heart failure
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FAS ANTIGEN;
FAS LIGAND;
FASLG PROTEIN, HUMAN;
HERBACEOUS AGENT;
MEMBRANE PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
ASTRAGALUS MEMBRANACEUS;
BIOSYNTHESIS;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG EFFECT;
FEMALE;
HUMAN;
INJECTION;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
PHYTOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
ANTIGENS, CD95;
APOPTOSIS;
ASTRAGALUS MEMBRANACEUS;
CORONARY DISEASE;
DRUGS, CHINESE HERBAL;
FAS LIGAND PROTEIN;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
INJECTIONS;
MALE;
MEMBRANE GLYCOPROTEINS;
MIDDLE AGED;
PHYTOTHERAPY;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 27744432718
PISSN: 10035370
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|